Related Experiment Videos

[Regional right ventricular hypertrophy in hypertrophic cardiomyopathy and hypertension]

Journal of Cardiography
|June 1, 1985
PubMed

Insights

Right ventricular hypertrophy (RVH) and asymmetric hypertrophy (AH) are more common in hypertrophic cardiomyopathy (HCM) and hypertensive asymmetric septal hypertrophy (HT-ASH) than in mild hypertension. Two-dimensional echocardiography (2DE) assessed these conditions.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Echocardiography

Context:

  • Hypertrophic cardiomyopathy (HCM) and hypertension (HT) can lead to cardiac structural changes.
  • Right ventricular hypertrophy (RVH) and asymmetric hypertrophy (AH) are specific manifestations of cardiac remodeling.
  • Two-dimensional echocardiography (2DE) is a key diagnostic tool for assessing cardiac morphology.

Purpose:

  • To compare the prevalence of right ventricular hypertrophy (RVH) and asymmetric hypertrophy (AH) in patients with hypertrophic cardiomyopathy (HCM) versus different categories of hypertensive heart disease.
  • To utilize two-dimensional echocardiography (2DE) to quantify right ventricular wall thickness and identify hypertrophic patterns.

Summary:

  • Echocardiographic assessment of 24 HCM patients and 51 hypertensive patients revealed distinct patterns of right ventricular hypertrophy (RVH).
  • The incidence of RVH and AH was significantly higher in HCM (67% RVH, 41% AH) and hypertensive patients with asymmetric septal hypertrophy (HT-ASH) (57% RVH, 45% AH) compared to mild hypertension (15% RVH, 11% AH).
  • Right ventricular hypertrophy with asymmetric hypertrophy was more frequent in HCM and HT-ASH groups.

Impact:

  • Highlights the increased likelihood of right ventricular remodeling in HCM and specific hypertensive heart disease subtypes.
  • Underscores the utility of echocardiography in differentiating cardiac conditions based on ventricular hypertrophy patterns.
  • Provides valuable data for understanding the spectrum of right ventricular involvement in cardiomyopathies and hypertensive heart disease.

Related Concept Videos